Anthem Biosciences
ANTHEM
Price
Mid Cap
₹48,495 Cr.
Anthem Biosciences, India’s fastest-growing CRDMO, offers end-to-end drug discovery, development, and manufacturing services across small molecules and biologics, serving global biotech and pharma firms with advanced, innovation-driven solutions.
Anthem Biosciences, India’s fastest-growing CRDMO, offers end-to-end drug discovery, development, a…
More
Anthem Biosciences, India’s fastest-growing CRDMO, offers end-to-end drug discovery, development, and manufacturing services across small molecules and biologics, serving global biotech and pharma firms with advanced, innovation-driven solutions.
Less
Low
701
High
870
PE
107.47
Sector PE
27.5
P/B
20.12
Div.Yield
--
ROE
18.73%
EBIDTA
--
ROCE
27.09
EPS
2.42
Niche index constructed using market cap and revenue exposure of companies in this sector
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
Yearly
|
Quarterly
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
Financial Ratio's
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
ANTHEM
Revenue Mix
Revenue Mix
This data is currently unavailable for this company.
ANTHEM
Revenue Mix
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
More Mid Cap Ideas
See similar 'Mid' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings